Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83197634 | 8319763 | 4 | F | 20110920 | 20160916 | 20120103 | 20160920 | EXP | US-PFIZER INC-2011310749 | PFIZER | 53.00 | YR | F | Y | 83.00000 | KG | 20160920 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 83197634 | 8319763 | 1 | SS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK, 2X/DAY | Y | 0 | TABLET | BID | |||||||
| 83197634 | 8319763 | 2 | SS | NAPROXEN. | NAPROXEN | 1 | Y | 0 | TABLET | ||||||||||
| 83197634 | 8319763 | 3 | PS | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, AS NEEDED | Y | 12151 | 25 | MG | TABLET | ||||||
| 83197634 | 8319763 | 4 | SS | LASIX | FUROSEMIDE | 1 | Oral | 40 MG, AS NEEDED | Y | 0 | 40 | MG | |||||||
| 83197634 | 8319763 | 5 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 40 MG, 2X/DAY | 89440 | MG | 0 | 40 | MG | BID | |||||
| 83197634 | 8319763 | 6 | C | IMITREX | SUMATRIPTAN SUCCINATE | 1 | Oral | 100 MG, AS NEEDED | 0 | 100 | MG | ||||||||
| 83197634 | 8319763 | 7 | C | PROMETHAZINE HYDROCHLORIDE. | PROMETHAZINE HYDROCHLORIDE | 1 | Oral | 25 MG, AS NEEDED | 0 | 25 | MG | ||||||||
| 83197634 | 8319763 | 8 | C | MULTIVITAMINS | VITAMINS | 1 | Oral | 1 TAB, 1X/DAY | 0 | QD | |||||||||
| 83197634 | 8319763 | 9 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | NS, INTRANASAL, 2X/DAY | 0 | 50 | UG | BID | ||||||||
| 83197634 | 8319763 | 10 | C | SOMA | CARISOPRODOL | 1 | Oral | 350 MG, 4X/DAY | 0 | 350 | MG | QID | |||||||
| 83197634 | 8319763 | 11 | C | REGLAN | METOCLOPRAMIDE HYDROCHLORIDE | 1 | Oral | 10 MG, AS NEEDED | 0 | 10 | MG | ||||||||
| 83197634 | 8319763 | 12 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | Oral | 20 MEQ, AS NEEDED | 0 | 20 | MEQ | ||||||||
| 83197634 | 8319763 | 13 | C | LIDODERM | LIDOCAINE | 1 | Transdermal | 5% Q, 12 HOUR, AS NEEDED, PATCH | 0 | 5 | PCT | ||||||||
| 83197634 | 8319763 | 14 | C | ALBUTEROL. | ALBUTEROL | 1 | Respiratory (inhalation) | 90 UG, AS NEEDED, INHALER | 0 | 90 | UG | ||||||||
| 83197634 | 8319763 | 15 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | 8 MG, Q 4 HOUR, AS NEEDED | 0 | 8 | MG | ||||||||
| 83197634 | 8319763 | 16 | C | TRAZODONE | TRAZODONE HYDROCHLORIDE | 1 | Oral | 50 MG, QHS, AS NEEDED | 0 | 50 | MG | ||||||||
| 83197634 | 8319763 | 17 | C | MS CONTIN | MORPHINE SULFATE | 1 | Oral | 60 MG, 4X/DAY | 0 | 60 | MG | QID | |||||||
| 83197634 | 8319763 | 18 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 2X/DAY | 0 | 500 | MG | BID | |||||||
| 83197634 | 8319763 | 19 | C | CELEXA | CITALOPRAM HYDROBROMIDE | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 83197634 | 8319763 | 1 | Osteoarthritis |
| 83197634 | 8319763 | 2 | Rheumatoid arthritis |
| 83197634 | 8319763 | 3 | Oedema |
| 83197634 | 8319763 | 4 | Oedema |
| 83197634 | 8319763 | 5 | Prophylaxis |
| 83197634 | 8319763 | 6 | Migraine |
| 83197634 | 8319763 | 7 | Nausea |
| 83197634 | 8319763 | 8 | Supplementation therapy |
| 83197634 | 8319763 | 9 | Rhinitis allergic |
| 83197634 | 8319763 | 10 | Muscle spasms |
| 83197634 | 8319763 | 11 | Gastrooesophageal reflux disease |
| 83197634 | 8319763 | 12 | Supplementation therapy |
| 83197634 | 8319763 | 13 | Fibromyalgia |
| 83197634 | 8319763 | 14 | Chronic obstructive pulmonary disease |
| 83197634 | 8319763 | 15 | Peripheral vascular disorder |
| 83197634 | 8319763 | 16 | Insomnia |
| 83197634 | 8319763 | 17 | Fibromyalgia |
| 83197634 | 8319763 | 18 | Type 2 diabetes mellitus |
| 83197634 | 8319763 | 19 | Depression |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 83197634 | 8319763 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 83197634 | 8319763 | Dehydration | |
| 83197634 | 8319763 | Gastroenteritis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 83197634 | 8319763 | 1 | 20080501 | 20111220 | 0 | |
| 83197634 | 8319763 | 3 | 2005 | 20110920 | 0 | |
| 83197634 | 8319763 | 4 | 2005 | 20110920 | 0 | |
| 83197634 | 8319763 | 5 | 20080829 | 20110920 | 0 | |
| 83197634 | 8319763 | 6 | 1988 | 0 | ||
| 83197634 | 8319763 | 8 | 1980 | 0 | ||
| 83197634 | 8319763 | 9 | 2006 | 0 | ||
| 83197634 | 8319763 | 10 | 2006 | 0 | ||
| 83197634 | 8319763 | 11 | 2004 | 0 | ||
| 83197634 | 8319763 | 12 | 2005 | 0 | ||
| 83197634 | 8319763 | 13 | 2004 | 0 | ||
| 83197634 | 8319763 | 14 | 2006 | 0 | ||
| 83197634 | 8319763 | 15 | 20090613 | 0 | ||
| 83197634 | 8319763 | 16 | 20100713 | 0 | ||
| 83197634 | 8319763 | 17 | 20101019 | 0 | ||
| 83197634 | 8319763 | 18 | 20090612 | 0 | ||
| 83197634 | 8319763 | 19 | 20100310 | 0 |